Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Pablo Tebas

Abstract

The contribution of current antiretroviral treatment regimens to the long-term survival of HIV-infected individuals is accompanied by increased risk of glucose metabolism abnormalities in this patient population. The risk of insulin resistance and diabetes in HIV-infected patients receiving antiretroviral treatment stems from 2 sources: exposure to the same environmental factors that have led to an increased incidence of these conditions in the general population and the negative effects on glucose metabolism inherent to components of antiretroviral treatment regimens. This article reviews the pathogenesis and diagnosis of insulin resistance and diabetes and the contribution of components of antiretroviral therapy regimens to increased risk for these conditions. Optimization of antiretroviral treatment regimens for HIV-infected patients with or at increased risk for development of abnormalities in glucose metabolism is discussed.

References

Apr 11, 1996·The New England Journal of Medicine·J P DesprésP J Lupien
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S CaroniaG J Alexander
May 12, 2000·The Journal of Biological Chemistry·H MurataM Mueckler
Jul 25, 2000·JAMA : the Journal of the American Medical Association·C HadiganS Grinspoon
Feb 7, 2001·The Journal of Clinical Endocrinology and Metabolism·C HadiganUNKNOWN Framingham Heart Study
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael P DubéThomas A Buchanan
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Henning Drechsler, William G Powderly
Mar 11, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jessica E JustmanKathryn Anastos
Jul 3, 2003·Journal of Lipid Research·Huan TranDudley K Strickland
Oct 28, 2003·Diabetes Care·Carlos LorenzoUNKNOWN San Antonio Heart Study
Apr 20, 2004·AIDS·Grace A LeeCarl Grunfeld
May 19, 2004·Annals of Internal Medicine·Colleen HadiganSteven Grinspoon
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marisa T GerberPablo Tebas
Aug 28, 2004·Expert Opinion on Pharmacotherapy·Stephen Becker, Lorna Thornton
Jan 7, 2005·The New England Journal of Medicine·Steven Grinspoon, Andrew Carr
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Feb 3, 2007·The New England Journal of Medicine·David M Nathan
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristin MondyKevin Yarasheski
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Jun 7, 2007·The New England Journal of Medicine·Philip D HomeUNKNOWN RECORD Study Group
Nov 21, 2007·AIDS·Handan WandUNKNOWN INITIO Trial International Coordinating Committee
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Jan 8, 2008·The American Journal of Clinical Nutrition·Gabriele RiccardiRosalba Giacco
Jan 11, 2008·Diabetes Care·Pirjo Ilanne-ParikkaUNKNOWN Finnish Diabetes Prevention Study Group
Jan 31, 2008·Advances in Cardiology·Doron Aronson

❮ Previous
Next ❯

Citations

Jul 26, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Supriya KrishnanDenise L Jacobson
Mar 19, 2014·The Journal of the Association of Nurses in AIDS Care : JANAC·Bernadette CapiliOlugbenga Ogedegbe
Feb 11, 2011·Current Infectious Disease Reports·Edgar Turner Overton, Michael T Yin
Jan 19, 2010·Expert Opinion on Drug Safety·Alessandra ViganòGian Vincenzo Zuccotti
Jun 5, 2013·Expert Opinion on Drug Safety·Jose V Fernandez-MonteroVicente Soriano
Jul 27, 2010·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·R Morillo VerdugoA Illaro Uranga
Mar 10, 2010·Bone·Gianvincenzo ZuccottiStefano Mora
Jun 23, 2011·Journal of Viral Hepatitis·M A LokoUNKNOWN ANRS CO 13 HEPAVIH Study Group
May 23, 2015·BioMed Research International·Pasquale MansuetoAntonio Cascio
Apr 21, 2012·Diabetes Care·Michaela Diamant, Michiel van Agtmael
Aug 12, 2014·Ophthalmology·John H KempenUNKNOWN Studies of Ocular Complications of AIDS Research Group
May 19, 2016·Expert Opinion on Pharmacotherapy·Karuna LamarcaPere Domingo
Jul 23, 2009·Annual Review of Medicine·Rohan HazraLynne M Mofenson
Apr 27, 2010·The Journal of Antimicrobial Chemotherapy·Susanna Naggie, Charles Hicks
Jun 6, 2009·Current Opinion in Lipidology·Munir Pirmohamed
Jun 23, 2012·European Journal of Epidemiology·Laura GalliAntonella Castagna
Jan 25, 2012·Clinical Medicine : Journal of the Royal College of Physicians of London·Hemantha Chandrasekara, Kevin Hardy
Jun 27, 2019·Current Topics in Medicinal Chemistry·Chandrashekhar Voshavar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.